KOVDAVIO Trademark

Trademark Overview

On Friday, May 21, 2021, a trademark application was filed for KOVDAVIO with the United States Patent and Trademark Office. The USPTO has given the KOVDAVIO trademark a serial number of 79314779. The federal status of this trademark filing is REGISTERED as of Tuesday, April 26, 2022. This trademark is owned by CELLTRION, INC.. The KOVDAVIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of COVID-19; antibodies for medical purposes, namely, immunological antibodies for medical purposes; Pharmaceuticals, namely, COVID-19 Pharmaceuticals; drugs for medical purposes for the treatment of COVID-19
kovdavio

General Information

Serial Number79314779
Word MarkKOVDAVIO
Filing DateFriday, May 21, 2021
Status700 - REGISTERED
Status DateTuesday, April 26, 2022
Registration Number6709102
Registration DateTuesday, April 26, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 8, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of COVID-19; antibodies for medical purposes, namely, immunological antibodies for medical purposes; Pharmaceuticals, namely, COVID-19 Pharmaceuticals; drugs for medical purposes for the treatment of COVID-19

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCELLTRION, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR
Party NameCELLTRION, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR
Party NameCELLTRION, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events

Event DateEvent Description
Monday, September 26, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 1, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 1, 2022FINAL DISPOSITION PROCESSED
Tuesday, July 26, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 26, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, February 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 8, 2022PUBLISHED FOR OPPOSITION
Sunday, February 6, 2022NOTIFICATION PROCESSED BY IB
Wednesday, January 19, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 19, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 13, 2021REFUSAL PROCESSED BY IB
Thursday, December 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 1, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 1, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 1, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 1, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 1, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 22, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, November 22, 2021REFUSAL PROCESSED BY MPU
Friday, November 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, October 26, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 25, 2021NON-FINAL ACTION WRITTEN
Thursday, October 21, 2021ASSIGNED TO EXAMINER
Tuesday, July 13, 2021APPLICATION FILING RECEIPT MAILED
Wednesday, July 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 1, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

kovdavio purposes covid medical treatment pharmaceuticals antibodies namely drugs preparations pharmaceutical